The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the ...

In recognition of their significant achievements to advance cancer care and research, Lauren Byers, M.D., and Paul Scheet, Ph ...

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response ...

Houston-based University of Texas MD Anderson Cancer Center and the University of Texas at Austin have launched a partnership in support of research projects designed to improve cancer prevention, ...

Glioblastoma is one of the most deadly and treatment-resistant cancers, according to the National Brain Tumor Society. It is ...

The University of Texas MD Anderson Cancer Center today announced that Jeffrey E. Lee, M.D., an internationally regarded ...

according to new data from researchers at The University of Texas MD Anderson Cancer Center. Five-year results from the Phase II trial, published today in JAMA Oncology, revealed that breast ...

HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations. The ...

While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk.

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...